VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of nucleosomes in whole venous blood in minutes ...

And Europe Lateral Flow Assay Market Report Highlights The kits & reagents segment led the market with the largest revenue share of 68.48% in 2024, driven by technological advancements and rising ...

The lateral flow assay market will exhibit the maximum CAGR over the forecast period 2025 to 2035 due to rising demand for diagnosis testing like infectious disease testing, pregnancy testing, and ...

The U.S. and Europe lateral flow assay market is expected to reach USD 6.97 billion by 2030, with a 5.48% CAGR from 2025. Growth is driven by the rise in point-of-care testing, advancements in testing ...

DCN Dx announced today that Jeremy Elser, Ph.D., Head of Science Operations at Palantir Technologies, will deliver the keynote address at the 2025 Advanced Lateral Flow Conference (ALFC), taking place ...

Many challenges exist in lateral flow assay (LFA) manufacturing, from low-volume liquid deposition to device assembly and packaging. In the development and batch-level manufacturing stage, antibody ...

Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...